PT-141 10mg
Frequently Bought Together
Complete Your Research Setup
Bacteriostatic water is required to reconstitute lyophilized peptides before use.
What You Should Know
Increases sexual desire at the brain level
Unlike most sexual health compounds that work through blood flow, PT-141 acts directly on the brain’s desire centers, addressing the root cause of low libido.
Works for both men and women
Clinical studies have shown significant improvements in sexual desire and arousal in both male and female participants. The FDA-approved version (Vyleesi) is based on this compound.
A fundamentally different approach
PT-141 represents a new class of sexual health compounds that work through the brain’s desire pathways rather than circulatory mechanisms, offering an option when other approaches haven’t worked.
A melanocortin receptor agonist studied for sexual health and libido through central nervous system pathways.
Unlike compounds that work through vascular mechanisms, PT-141 acts directly on melanocortin receptors in the brain (specifically MC3R and MC4R), addressing desire and arousal at the neurological level.
Clinical studies have observed significant improvements in sexual desire and arousal in both male and female subjects. The FDA-acknowledged version (bremelanotide/Vyleesi) is based on this compound.
PT-141 represents a fundamentally different approach to sexual health research — working through the brain’s desire pathways rather than circulatory mechanisms.
Quality: ≥99% (HPLC) · Third-party tested
All Elystra Bio products are third-party tested for identity, purity, and potency. Certificates of analysis are available upon request.
Melanocortin agonist — CNS & sexual behavior research.
“PT-141 (Bremelanotide) is a cyclic heptapeptide melanocortin receptor agonist derived from Melanotan 2. Research focuses on MC3R and MC4R activation in the central nervous system, with applications in sexual behavior neuroscience, autonomic nervous system function, and melanocortin pathway signaling studies.”
Description
PT-141 (Bremelanotide) is a cyclic heptapeptide melanocortin receptor agonist derived from Melanotan 2. Research focuses on MC3R and MC4R activation in the central nervous system, with applications in sexual behavior neuroscience, autonomic nervous system function, and melanocortin pathway signaling studies.
Related products
-
Research Profile
A synergistic combination of two GH-releasing peptides that work through complementary pathways for amplified growth hormone output.
≥99% (HPLC) · Third-party tested
CJC-1295/Ipamorelin 10mg
Research Use Only $89.99 Add to cart -
Research Profile
A growth hormone-releasing hormone (GHRH) analog that stimulates natural growth hormone production from the pituitary gland.
≥99% (HPLC) · Third-party tested
Sermorelin 10mg
Research Use Only $79.99 Add to cart -
Research Profile
A cyclic peptide analog of alpha-MSH studied for melanocortin receptor activation and skin pigmentation research.
≥99% (HPLC) · Third-party tested
Melanotan 2 10mg
Research Use Only $39.99 Add to cart -
Research Profile
A thymic peptide extensively studied for immune system support and modulation.
≥99% (HPLC) · Third-party tested
Thymosin Alpha 1 10mg
Research Use Only $49.99 Add to cart
For research purposes only. Not for human consumption. All products are third-party tested.
Reviews
There are no reviews yet.